Related Experiment Video

Updated: Mar 3, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K

Vaccine uptake in children and young people

Lynne Pearce

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |May 4, 2017
    PubMed

    Insights

    The National Institute for Health and Care Excellence (NICE) released new quality standards in March focusing on vaccine uptake for individuals under 19. These guidelines aim to improve immunization rates in this age group.

    Area of Science:

    • Public Health
    • Immunization Policy

    Background:

    • Vaccine uptake in adolescents and children is crucial for community immunity.
    • Ensuring high vaccination rates prevents outbreaks of preventable diseases.

    Purpose of the Study:

    • To outline the latest quality standards for vaccine uptake in the under-19 population.
    • To provide evidence-based recommendations for healthcare providers and policymakers.

    Main Methods:

    • Review of existing literature and guidelines.
    • Development of quality indicators by the National Institute for Health and Care Excellence (NICE).

    Main Results:

    • Publication of new NICE quality standards in March.
    • Specific recommendations targeting vaccine uptake in the under-19 demographic.

    Conclusions:

    • The new standards provide a framework for improving childhood and adolescent vaccination coverage.
    • Adherence to these NICE guidelines is expected to enhance public health outcomes.

    More Related Videos

    Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique09:37

    Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

    Published on: September 23, 2022

    2.3K
    Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

    Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

    Published on: February 22, 2019

    11.4K

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    52.5K
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    411
    Cancer Vaccines01:30

    Cancer Vaccines

    Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
    Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
    1.2K
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    388
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    293
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    457